Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
120.17B | 120.98B | 107.63B | 101.90B | 105.79B | 132.96B | Gross Profit |
9.84B | 9.58B | 7.37B | 8.40B | 10.38B | 11.91B | EBIT |
3.33B | 3.32B | 1.53B | 2.25B | 4.60B | 5.95B | EBITDA |
3.56B | 4.66B | 3.68B | 3.92B | 5.99B | 7.12B | Net Income Common Stockholders |
1.81B | 2.74B | 2.25B | 1.81B | 3.22B | 4.46B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
25.82B | 17.49B | 17.58B | 33.70B | 48.82B | 29.21B | Total Assets |
195.31B | 203.61B | 155.75B | 155.10B | 153.36B | 172.31B | Total Debt |
33.40B | 33.49B | 13.60B | 13.71B | 13.36B | 13.56B | Net Debt |
7.58B | 16.00B | -3.98B | -19.99B | -35.45B | -15.65B | Total Liabilities |
100.29B | 110.69B | 76.53B | 80.80B | 78.76B | 103.97B | Stockholders Equity |
95.02B | 92.93B | 79.22B | 74.30B | 74.61B | 68.33B |
Cash Flow | Free Cash Flow | ||||
0.00 | -22.97B | -16.25B | -14.24B | 20.50B | -4.02B | Operating Cash Flow |
0.00 | -22.39B | -2.91B | -13.72B | 21.26B | -3.50B | Investing Cash Flow |
0.00 | 2.67B | -12.98B | -1.41B | -716.00M | -755.00M | Financing Cash Flow |
0.00 | 19.30B | -696.00M | -394.00M | -948.00M | -989.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥23.15B | 7.71 | 1.96% | -14.89% | -28.68% | ||
80 Outperform | ¥32.99B | 11.46 | 4.44% | 2.36% | 136.74% | ||
72 Outperform | ¥29.62B | 8.45 | 2.90% | -0.26% | 28.01% | ||
72 Outperform | ¥22.92B | 7.89 | 3.30% | 2.91% | 9.79% | ||
67 Neutral | ¥32.99B | 14.92 | 2.77% | 2.37% | 10.25% | ||
66 Neutral | $4.51B | 12.29 | 5.40% | 248.53% | 4.14% | -12.41% | |
65 Neutral | ¥23.50B | 7.33 | 2.67% | -4.84% | -16.47% |